ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Avidity Biosciences Announces Proposed Public Offering of Common Stock
August 03, 2021Avidity Biosciences, Inc. (Nasdaq: RNA) today announced that it intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering. -
Avidity Biosciences Announces 2021 Pipeline Updates and Research Collaboration with MyoKardia
January 11, 2021Avidity Biosciences, Inc. announced pipeline updates for 2021 and a research collaboration with MyoKardia, Inc., a wholly-owned subsidiary of Bristol Myers Squibb. -
Lilly, Avidity Biosciences Enter Global R&D Alliance
April 23, 2019Will leverage Avidity's technology platform for the discovery, development and commercialization of potential new medicines in immunology and other indications...
Pharma Sources Insight January 2025
